Stryker launches Gamma4 Hip Fracture Nailing System in Europe
New system streamlines workflows and enhances usability
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240326868923/en/
The Gamma4 System is indicated for the treatment of fractures in the intracapsular, trochanteric, subtrochanteric and shaft regions of the femur (including osteoporotic and osteopenic bone). (Photo: Business Wire)
“The Gamma4 system represents the latest chapter of the Gamma legacy, and we are excited to expand availability to our European customers after a successful launch in the U.S.,” said
Used in over 25,000 cases in
- A redefined nail design. Designed using our SOMA database of over 34,000 3D bone models generated from CT scans1, Gamma4 has a chamfered distal tip, a 5mm shorter proximal body compared to Gamma3, and a length-dependent radius of curvature (RoC) for long nails2, enhancing anatomical fit and usability.
- Improved workflow. The Precision Pin™ offers more resistance to pull out, and the potential for skiving is reduced by 66% compared to a standard ∅3.2 K-wire.3
- Integrated instrument platform. Gamma4 and T2Alpha nails now all work on the same instrument platform, standardizing surgical procedures.
“The Gamma system has evolved through streamlined processes, standardization and meticulous attention to detail, all crafted to elevate operative techniques and enhance usability,” said Dr.
About Stryker
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at www.stryker.com.
A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery.
The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area.
Content ID: G4-AD-13, 02-2024
References
- Internal report D0000124129, Rev AD
- Internal Report № D0000089997, Rev AA
- Stryker: Internal test report D0000099352, Rev AE
View source version on businesswire.com: https://www.businesswire.com/news/home/20240326868923/en/
Media Contact
President/CEO,
asampson@sampsonprgroup.com
562.304.0301
Source: Stryker